Universal Beteiligungs und Servicegesellschaft mbH Sells 324,987 Shares of Core Scientific, Inc. $CORZ

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH cut its stake in Core Scientific by 71.8% in Q4, selling 324,987 shares and retaining 127,819 shares valued at about $1.87 million.
• Insider Todd M. Duchene sold 10,000 shares on April 27 at an average of $20.94, joining insider sales of 40,000 shares (~$724,800) over the past three months; insiders now own 1.70% of the company.
• Core Scientific (CORZ) trades near $20.35 with a 52‑week range of $8.39–$23.63 and a $6.42B market cap; it reported an EPS beat ($0.42 vs. -$0.27) but revenue missed and fell 16% YoY, while analysts have a consensus Moderate Buy and an average target of $25.07.

Universal Beteiligungs und Servicegesellschaft mbH lowered its position in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 71.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 127,819 shares of the company's stock after selling 324,987 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH's holdings in Core Scientific were worth $1,866,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CORZ. Allworth Financial LP raised its stake in shares of Core Scientific by 206.5% in the third quarter. Allworth Financial LP now owns 1,410 shares of the company's stock valued at $25,000 after acquiring an additional 950 shares during the last quarter. Osaic Holdings Inc. raised its stake in shares of Core Scientific by 112.1% in the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company's stock valued at $34,000 after acquiring an additional 1,066 shares during the last quarter. Russell Investments Group Ltd. raised its stake in shares of Core Scientific by 61.9% in the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company's stock valued at $67,000 after acquiring an additional 1,507 shares during the last quarter. Athos Capital Ltd bought a new position in shares of Core Scientific in the third quarter valued at approximately $76,000. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Core Scientific in the third quarter valued at approximately $90,000.

Core Scientific Price Performance

CORZ stock opened at $20.35 on Friday. The company has a 50 day moving average price of $17.41 and a 200 day moving average price of $17.44. Core Scientific, Inc. has a fifty-two week low of $8.39 and a fifty-two week high of $23.63. The stock has a market capitalization of $6.42 billion, a PE ratio of 17.39 and a beta of 5.47.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.69. The company had revenue of $79.76 million during the quarter, compared to the consensus estimate of $118.45 million. During the same quarter last year, the firm earned ($0.69) EPS. The business's revenue for the quarter was down 16.0% on a year-over-year basis. As a group, equities analysts expect that Core Scientific, Inc. will post 0.07 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Todd M. Duchene sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $20.94, for a total value of $209,400.00. Following the completion of the transaction, the insider owned 1,990,348 shares in the company, valued at $41,677,887.12. The trade was a 0.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last three months, insiders have sold 40,000 shares of company stock valued at $724,800. Insiders own 1.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on CORZ shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Core Scientific in a research note on Monday, April 20th. HC Wainwright reiterated a "buy" rating and issued a $25.00 target price on shares of Core Scientific in a research note on Tuesday, March 3rd. Zacks Research upgraded shares of Core Scientific from a "strong sell" rating to a "hold" rating in a research note on Tuesday, January 13th. Wall Street Zen upgraded shares of Core Scientific to a "sell" rating in a research note on Saturday, March 14th. Finally, LADENBURG THALM/SH SH cut their target price on shares of Core Scientific from $24.50 to $23.75 and set a "buy" rating for the company in a research note on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $25.07.

About Core Scientific

Core Scientific, Inc NASDAQ: CORZ is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific's service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Want to see what other hedge funds are holding CORZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Scientific, Inc. (NASDAQ:CORZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.